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A 52-year-old man presenting with severely symptomatic chronic mesenteric ischemia
had proximal occlusion of the celiac and superior mesenteric arteries and critical stenosis
of the inferior mesenteric artery ostium. Concurrent percutaneous revascularization with
stenting of all three mesenteric arteries was successfully achieved using techniques
tailored to each lesion. Complete clinical recovery was observed at the six-month post-
procedure follow-up.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Introduction
Endovascular therapy is now considered the first treatment
option in most patients with chronic mesenteric ischemia
(CMI) secondary to atherosclerotic occlusive disease of the
mesenteric arteries.1e3 In comparison to open surgery, endo-
vascular therapy for CMI has less morbidity, lower or com-
parable mortality, and shorter in-hospital stay; however it is
associated with a more frequent need for re-intervention,1e5
which could be partly related to incomplete revasculariza-
tion.1,4 Obstruction of two or all three mesenteric arteries is
usually required to cause CMI, and in keeping with theiology, Christian Medical
Joseph).
ciety of India. All rightssurgical principle of revascularizingmore than one obstructed
mesenteric artery,6 endovascular treatment of multiple
mesenteric vessels improves clinical outcomes.3,4 However,
revascularization of multiple mesenteric arteries frequently
entails recanalization of totally occluded arteries, which can
be technically challenging. Until now endovascular pro-
cedures involving revascularization of mesenteric arteries in
CMI have largely been restricted to one or two arteries.7,8 We
report a severely symptomatic case of CMI in which all three
mesenteric arteries, two of which were total occlusions, were
concurrently and successfully revascularized by endovascular
technique.College, Vellore, 632004, India. Tel.: þ91 416 2282147; fax: þ91 416
reserved.
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A 52-year-oldman presentedwith a history of abdominal pain
and occasional vomiting after food intake, associated with
progressive loss of weight, for the last two years. He had dia-
betes mellitus, systemic hypertension, and dyslipidemia, and
was a chronic smoker. Physical examination was unremark-
able except for significant emaciation (body mass index
16.9 kg/m2) and left below-knee amputation from a past ac-
cident. Blood tests, abdominal ultrasonography and upper
gastro-intestinal endoscopy were non-contributory. CT angi-
ography revealed proximal occlusion of the celiac and supe-
rior mesenteric arteries and critical ostial narrowing of the
inferior mesenteric artery, with distal patency of all three
vessels. Conventional angiography (Figs. 1A and 2A,C)
confirmed these findings and also detected non-critical
(asymptomatic) coronary artery disease. A percutaneous
approach to revascularizing the obstructedmesenteric vessels
was preferred in view of the multiple medical co-morbidities.3. Intervention
After obtaining written informed consent, percutaneous 7F
right femoral artery access was obtained. 5000 units of
heparin was administered. After baseline angiography, the
celiac artery ostium was engaged with a 7F Judkins Right
guiding catheter and the proximal occlusion was traversed
using a 0.01400Conquest wire (Asahi Intecc, Aichi, Japan),
after softer wires failed to penetrate the proximal cap. Serial
balloon dilatation was followed by implantation of two over-Fig. 1 e Abdominal aortograms in antero-posterior projection. A
aorta, severe ostial stenosis of the inferior mesenteric artery (a
mesenteric arteries. B. Post-stenting angiogram showing recan
lower white arrows respectively) and stented inferior mesenterlapping 6 mm diameter balloon-expandable stents (Dynamic
Renal, Biotronik AG, Bulach, Switzerland) of lengths 19 and
12 mm extending distally into the hepatic artery; the second
stent was necessary since the first did not cover the celiac
artery ostium adequately; the origin of the splenic artery was
jailed by the stents, but normal flow into this branch was
preserved. Next, using the same guiding catheter, the su-
perior mesenteric artery occlusion was probed and suc-
cessfully crossed with an angled-tip 0.03500 hydrophilic
guidewire (Terumo Medical, Somerset, NJ, USA); this wire
was changed to a 0.03500 Amplatz Superstiff guidewire (Bos-
ton Scientific, Marlborough, MA, USA) through a 4F hydro-
philic catheter (Terumo); the lesion was dilated and stented
using a 8  37 mm balloon-expandable stent (Express LD,
Boston Scientific) delivered through a 7F long sheath (Ansel,
Cook Medical, Bloomington, IN, USA). Lastly, the ostial ste-
nosis of the inferior mesenteric artery was crossed using a
soft hydrophilic 0.01400 wire (Fielder, Asahi) and stented with
a 6  18 mm balloon-expandable stent (Express SD). In all
the arteries treated, stent diameters were matched with the
normal vessel beyond the lesion and stent length was cho-
sen to ensure coverage from the aortic lumen to the normal
vessel just distal to the lesion. Final angiography (Figs. 1B
and 2B,D) showed a good result in all three mesenteric ves-
sels, with no residual stenosis or dissection and rapid flow
into the distal branches. The sheath was removed immedi-
ately and hemostasis was obtained by manual compression.
The total fluoroscopy time was 46 mins and 250 ml of
iodinated contrast was used. The hospital stay was un-
eventful and the patient was discharged after two days
without any complication. The patient's symptoms were
completely relieved by the procedure. There was rapid. Baseline angiogram showing atherosclerotic abdominal
rrow) and non-visualization of the celiac and superior
alized celiac and superior mesenteric arteries (upper and
ic artery (black arrow).
Fig. 2 e A, B. Abdominal aortograms in left lateral projection before (A) and after (B) celiac artery (upper arrow) and superior
mesenteric artery (lower arrow) recanalization and stenting. C, D. Selective inferior mesenteric artery angiograms in right
anterior oblique projection showing severe ostial stenosis with distal contrast streaming at baseline (C) and widely patent
vessel post-stenting (D).
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slower additional weight gain of 14 kg to attain a body mass
index of 24.1 kg/m2 (body weight 72 kg) by six-months post-
procedure, at which time the patient continued to remain
asymptomatic.4. Discussion
All patients with symptomatic CMI need to undergo revascu-
larization of the mesenteric vessels to achieve relief from
post-prandial abdominal pain, restoration of nutritional sta-
tus and prevention of bowel infarction. As CMI is most oftencaused by obstruction of more than one mesenteric artery, it
stands to reason that as many mesenteric vessels be revas-
cularized as is feasible and safe in order to maximize the
treatment effect. Surgical results have shown that although
single-vessel revascularization may relieve symptoms, com-
plete revascularization of all obstructed vessels is required to
obtain optimal long-term results.6 Similar findings have been
seen with endovascular therapy of CMI, where two-vessel
treatment was more protective against symptom recurrence
and need for re-intervention than single-vessel treatment.3
Kougias et al4 attributed the fact that surgically treated CMI
patients were more likely to experience long-term symptom-
atic relief than patients treated by endovascular therapy to the
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gical group.
Endovascular therapy for CMI is associatedwith shorter in-
hospital stay, lowermorbidity and lower or comparable short-
and long-term mortality when compared to open surgery;
however, early restenosis and the need for further interven-
tion is more common in the endovascular group.1e5 Oderich9
found 47% restenosis after endovascular therapy for CMI
with bare metal stents. Given this trend towards more
frequent restenosis in the endovascular group, revasculari-
zation of multiple obstructed vessels becomes all the more
important so that alternative channels of mesenteric blood
supply are present in case restenosis occurs in some of the
revascularized vessels.
Endovascular treatment of CMI often involves recanaliza-
tion of occluded arteries, especially when multiple obstructed
mesenteric vessels have to be revascularized; in a study by
Sarac7 28% of 87 lesions treated for CMI were occlusions.
Percutaneous recanalization of occluded mesenteric vessels
can be technically challenging, and may be one reason why
the proportion of patients receiving two-vessel revasculari-
zation in endovascular series is lower than that in surgical
series.4 Difficulty in revascularization of chronic mesenteric
artery occlusions has necessitated modifications in the ante-
grade technique10 and the use of retrograde transcollateral
approaches.11,12 A recent study of endovascular therapy for
chronic mesenteric artery occlusions has reported high tech-
nical success rate (87%) with no major complications8;
another encouraging finding is that endovascular therapy for
chronic mesenteric artery occlusions produces outcomes
similar to that in stenotic arteries.7
There is only one previous case report of concurrent
revascularization of all three mesenteric arteries in CMI13; in
that case, which was done emergently in combination with
bowel resection, only one vessel, the superior mesenteric ar-
tery, was occluded, and it was recanalized by retrograde
technique through a collateral channel. Our patient, who
underwent elective concurrent revascularization of all three
mesenteric arteries, had total occlusions in two of the arteries;
both these were recanalized antegradely, but with different
techniques, as the characteristics of the occlusions were dis-
similar: in the celiac artery a fine, stiff non-hydrophilic wire
was required as no soft path could be found within the oc-
clusion and sharp penetration was required, whereas in the
superior mesenteric artery a thicker, soft hydrophilic wire
could be manipulated through the occlusion into the vessel
lumen distally. Enthusiasm for multi-vessel endovascular
therapy for CMI should be tempered against the risk of com-
plications occurring during the procedure, the most signifi-
cant of which are bowel necrosis due to distal embolization
and arterial dissection14; mesenteric artery complications
during endovascular therapy for CMI result in greater mor-
tality, morbidity, and length of hospital stay.155. Conclusion
This case demonstrates that concurrent percutaneous triple-
vessel mesenteric artery revascularization for CMI using
contemporary technique can be safely accomplished evenwith two vessels occluded and the third critically stenosed; its
use in appropriate cases could help to make mesenteric
revascularization more complete and provide durable relief
from symptoms to patients presenting with CMI.Conflicts of interest
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